Logo image of ZUMZ

ZUMIEZ INC (ZUMZ) Stock Fundamental Analysis

NASDAQ:ZUMZ - Nasdaq - US9898171015 - Common Stock - Currency: USD

12.05  +0.39 (+3.34%)

After market: 12.05 0 (0%)

Fundamental Rating

4

ZUMZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. No worries on liquidiy or solvency for ZUMZ as it has an excellent financial health rating, but there are worries on the profitability. ZUMZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ZUMZ had negative earnings in the past year.
ZUMZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZUMZ reported negative net income in multiple years.
ZUMZ had a positive operating cash flow in 4 of the past 5 years.
ZUMZ Yearly Net Income VS EBIT VS OCF VS FCFZUMZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

ZUMZ's Return On Assets of -0.27% is in line compared to the rest of the industry. ZUMZ outperforms 44.63% of its industry peers.
ZUMZ's Return On Equity of -0.52% is in line compared to the rest of the industry. ZUMZ outperforms 51.24% of its industry peers.
ZUMZ's Return On Invested Capital of 0.32% is on the low side compared to the rest of the industry. ZUMZ is outperformed by 62.81% of its industry peers.
Industry RankSector Rank
ROA -0.27%
ROE -0.52%
ROIC 0.32%
ROA(3y)-2.3%
ROA(5y)2.92%
ROE(3y)-4.36%
ROE(5y)5.23%
ROIC(3y)N/A
ROIC(5y)N/A
ZUMZ Yearly ROA, ROE, ROICZUMZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

ZUMZ's Operating Margin of 0.22% is on the low side compared to the rest of the industry. ZUMZ is outperformed by 62.81% of its industry peers.
ZUMZ's Operating Margin has declined in the last couple of years.
ZUMZ has a Gross Margin of 34.08%. This is comparable to the rest of the industry: ZUMZ outperforms 43.80% of its industry peers.
ZUMZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.22%
PM (TTM) N/A
GM 34.08%
OM growth 3Y-69.24%
OM growth 5Y-45.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.98%
GM growth 5Y-0.75%
ZUMZ Yearly Profit, Operating, Gross MarginsZUMZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

8

2. Health

2.1 Basic Checks

ZUMZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ZUMZ has less shares outstanding than it did 1 year ago.
ZUMZ has less shares outstanding than it did 5 years ago.
There is no outstanding debt for ZUMZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZUMZ Yearly Shares OutstandingZUMZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ZUMZ Yearly Total Debt VS Total AssetsZUMZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

ZUMZ has an Altman-Z score of 2.49. This is not the best score and indicates that ZUMZ is in the grey zone with still only limited risk for bankruptcy at the moment.
ZUMZ has a Altman-Z score of 2.49. This is comparable to the rest of the industry: ZUMZ outperforms 57.85% of its industry peers.
There is no outstanding debt for ZUMZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.49
ROIC/WACC0.03
WACC9.24%
ZUMZ Yearly LT Debt VS Equity VS FCFZUMZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

ZUMZ has a Current Ratio of 2.07. This indicates that ZUMZ is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ZUMZ (2.07) is better than 83.47% of its industry peers.
ZUMZ has a Quick Ratio of 1.13. This is a normal value and indicates that ZUMZ is financially healthy and should not expect problems in meeting its short term obligations.
ZUMZ has a Quick ratio of 1.13. This is in the better half of the industry: ZUMZ outperforms 76.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.13
ZUMZ Yearly Current Assets VS Current LiabilitesZUMZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.15% over the past year.
Looking at the last year, ZUMZ shows a small growth in Revenue. The Revenue has grown by 1.57% in the last year.
ZUMZ shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.97% yearly.
EPS 1Y (TTM)98.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.09%
Revenue 1Y (TTM)1.57%
Revenue growth 3Y-9.1%
Revenue growth 5Y-2.97%
Sales Q2Q%-0.94%

3.2 Future

Based on estimates for the next years, ZUMZ will show a very strong growth in Earnings Per Share. The EPS will grow by 173.06% on average per year.
The Revenue is expected to grow by 2.41% on average over the next years.
EPS Next Y513.66%
EPS Next 2Y233.52%
EPS Next 3Y173.06%
EPS Next 5YN/A
Revenue Next Year0.97%
Revenue Next 2Y1.34%
Revenue Next 3Y2.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZUMZ Yearly Revenue VS EstimatesZUMZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ZUMZ Yearly EPS VS EstimatesZUMZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

ZUMZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 48.55 indicates a quite expensive valuation of ZUMZ.
The rest of the industry has a similar Price/Forward Earnings ratio as ZUMZ.
ZUMZ is valuated expensively when we compare the Price/Forward Earnings ratio to 20.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 48.55
ZUMZ Price Earnings VS Forward Price EarningsZUMZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

ZUMZ's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 40.53
EV/EBITDA 0
ZUMZ Per share dataZUMZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZUMZ's earnings are expected to grow with 173.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y233.52%
EPS Next 3Y173.06%

0

5. Dividend

5.1 Amount

ZUMZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZUMIEZ INC

NASDAQ:ZUMZ (5/2/2025, 8:00:02 PM)

After market: 12.05 0 (0%)

12.05

+0.39 (+3.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)06-04 2025-06-04/amc
Inst Owners82.05%
Inst Owner Change0%
Ins Owners20.72%
Ins Owner Change0.79%
Market Cap230.88M
Analysts47.5
Price Target18.36 (52.37%)
Short Float %7.34%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)65.44%
Min EPS beat(2)-4.41%
Max EPS beat(2)135.29%
EPS beat(4)3
Avg EPS beat(4)61.25%
Min EPS beat(4)-4.41%
Max EPS beat(4)135.29%
EPS beat(8)5
Avg EPS beat(8)-55.16%
EPS beat(12)7
Avg EPS beat(12)-42.07%
EPS beat(16)10
Avg EPS beat(16)130.42%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.57%
Max Revenue beat(2)-1.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.22%
Min Revenue beat(4)-2.57%
Max Revenue beat(4)2.03%
Revenue beat(8)4
Avg Revenue beat(8)-0.38%
Revenue beat(12)6
Avg Revenue beat(12)-0.36%
Revenue beat(16)7
Avg Revenue beat(16)0.42%
PT rev (1m)-14.29%
PT rev (3m)-23.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-112.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-71.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 48.55
P/S 0.26
P/FCF 40.53
P/OCF 11.15
P/B 0.7
P/tB 0.77
EV/EBITDA 0
EPS(TTM)-0.06
EYN/A
EPS(NY)0.25
Fwd EY2.06%
FCF(TTM)0.3
FCFY2.47%
OCF(TTM)1.08
OCFY8.97%
SpS46.41
BVpS17.17
TBVpS15.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.52%
ROCE 0.41%
ROIC 0.32%
ROICexc 0.46%
ROICexgc 0.51%
OM 0.22%
PM (TTM) N/A
GM 34.08%
FCFM 0.64%
ROA(3y)-2.3%
ROA(5y)2.92%
ROE(3y)-4.36%
ROE(5y)5.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-71.81%
ROICexcg growth 5Y-43.58%
ROICexc growth 3Y-70.67%
ROICexc growth 5Y-42.87%
OM growth 3Y-69.24%
OM growth 5Y-45.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.98%
GM growth 5Y-0.75%
F-Score7
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 67.71%
Cap/Sales 1.69%
Interest Coverage 250
Cash Conversion 85.86%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 1.13
Altman-Z 2.49
F-Score7
WACC9.24%
ROIC/WACC0.03
Cap/Depr(3y)91.88%
Cap/Depr(5y)76.39%
Cap/Sales(3y)2.23%
Cap/Sales(5y)1.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.09%
EPS Next Y513.66%
EPS Next 2Y233.52%
EPS Next 3Y173.06%
EPS Next 5YN/A
Revenue 1Y (TTM)1.57%
Revenue growth 3Y-9.1%
Revenue growth 5Y-2.97%
Sales Q2Q%-0.94%
Revenue Next Year0.97%
Revenue Next 2Y1.34%
Revenue Next 3Y2.41%
Revenue Next 5YN/A
EBIT growth 1Y103.01%
EBIT growth 3Y-72.04%
EBIT growth 5Y-47.44%
EBIT Next Year6979.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y201.82%
FCF growth 3Y-63.72%
FCF growth 5Y-42%
OCF growth 1Y40.3%
OCF growth 3Y-46.48%
OCF growth 5Y-27.81%